Stem Cell Research

Preclinical study indicates umbilical cord stem cells improve heart function

Published in Blood Weekly, September 29th, 2005

ViaCell, Inc. (VIAC) announced the publication of results of a preclinical study demonstrating that administration of stem cells sourced from umbilical cord blood and using ViaCell's proprietary process significantly improved heart function in an in vivo model of myocardial infarction (heart attack).

The results of the preclinical study, sponsored by ViaCell and conducted in association with the Toronto General Research Institute at Toronto General Hospital under the supervision of Dr. Ren Ke-Li, have been published in the August 30,2005 Cardiovascular Surgery Supplement of Circulation: Journal of the American Heart Association.

As described...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2005-09-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry